home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Bridges Home Healthcare

SHARESHARESHARE
Bridges Home Healthcare is a full service home health care agency, offering both medical and non-medical home care throughout Southeastern Wisconsin. Our service area covers the counties of Dodge, Washington, Ozaukee, Milwaukee, Waukesha, Racine and Kenosha. At Bridges Home Healthcare, we strive to bridge the gap between personal health, financial resource, and health care. Our primary goal is to help create a community of caring, safety, and positive health outcomes while maintaining a holistic and cohesive continuum of care for the patient caregiver healthcare provider relationship.
SHARESHARESHARE

RELATED NEWS


Amplyx Pharmaceuticals (San Diego, CA) has appointed Ciara Kennedy, Ph.D., to president and chief executive officer and Karen Joy Shaw, Ph.D., to chief scientific officer (CSO). The company's former president and CEO, Mike Grey, has assumed the role of executive chairman of the Amplyx Board of Directors....
PHARMEXEC.COM
READ MORE

Obesity has become one of the most significant challenges to human health. But now scientists at the University of Aberdeen Rowett Institute have discovered a tiny group of brain cells that could be harnessed to tackle obesity according to a new study published in Cell Metabolism. The team's research has seen them unlock the role of these cells in current and emerging obesity medications that mimic our brain chemical called serotonin. Lead scientist, Professor Heisler, Chair in Human Nutriti...

READ MORE

Catalent Pharma Solutions (Stand A80), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products....

READ MORE

Scientists from Newcastle University and the UK's ISIS Neutron and Muon research facility have worked together on a new project that is increasing our understanding of how antibiotics treat bacteria. With the number of antibiotic-resistant bacteria increasing in recent years, the ability to develop a way to combat this resistance could be essential for our future health. The team used a technique known as neutron reflectometry at STFC's ISIS facility in Oxfordshire to examine how Polymyx...

READ MORE

Approximately 2,200 Americans die each day from heart attacks, strokes and other cardiovascular diseases. The most common cause is blocked blood vessels that can no longer supply oxygen and nutrients to the heart and brain. A recent study has shown that a protein inhibitor drug prevents these blockages, and could be a new therapeutic approach to prevent heart attack, stroke and other diseases caused by blocked blood vessels....
.SCIENCEDAILY.COM
READ MORE

Snow Capital Management LP reduced its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) by 10.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 965,986 shares of the company’s stock after selling 110,053 shares during the period…...
BASEBALL NEWS SOURCE
READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...